Results 201 to 210 of about 28,819 (218)

PROTAC targeted protein degraders: the past is prologue

Nature Reviews Drug Discovery, 2022
Miklos Bekes, David R Langley, Craig M Crews   +2 more
exaly  

Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations

Ca-A Cancer Journal for Clinicians, 2020
Michelle C Turner, Zorana Jovanovic Andersen, Andrea A Baccarelli   +2 more
exaly  

Status and perspectives of crystalline silicon photovoltaics in research and industry

Nature Reviews Materials, 2022
Christophe Ballif, Franz-Josef Haug, Mathieu Boccard   +2 more
exaly  

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

Nature Reviews Microbiology, 2022
Véronique A Dartois, Eric J Rubin
exaly  

The fundamentals and applications of ferroelectric HfO2

Nature Reviews Materials, 2022
Uwe Schroeder, Min Hyuk Park, Thomas Mikolajick   +2 more
exaly  

Emerging applications of zeolites in catalysis, separation and host–guest assembly

Nature Reviews Materials, 2021
Yi Li, Yu Jihong
exaly  

A blueprint for the primary prevention of cancer: Targeting established, modifiable risk factors

Ca-A Cancer Journal for Clinicians, 2018
Susan M Gapstur, Eric J Jacobs, Lauren R Teras   +2 more
exaly  

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

Nature Reviews Drug Discovery, 2010
Harald Hampel, Stefan J Teipel, John Hardy   +2 more
exaly  

Opportunities and challenges in phenotypic drug discovery: an industry perspective

Nature Reviews Drug Discovery, 2017
Fabien Vincent, Jonathan A Lee, Marco Prunotto   +2 more
exaly  

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

Chemical Reviews, 2014
Santos Fustero, Vadim A Soloshonok, Hong Liu   +2 more
exaly